The predominant localisation of VEGFR-2 has been shown by immunohistochemistry-based analysis to be in endothelial cells, yet expression has also been identified in epithelial cells in breast cancer (de Jong et al, 1998; Kranz et al, 1999; Ryden et al, 2003). This evidence concerns the gene KDR and breast cancer.